Health AI Central
Share:
Peer-Reviewed Publication
Health Aff Sch2024;2(11):qxae133.November 1, 2024Journal Article

Increased spending on low-value care during the COVID-19 pandemic in Virginia.

Michelle S Rockwell1, Sitaram Vangala2, Jillian Rider3, Beth Bortz4, Kyle Russell3, Marcos Dachary5, Lauryn Walker4, A Mark Fendrick6, John N Mafi7,8
1Department of Family and Community Medicine, Virginia Tech Carilion School of Medicine, Roanoke, VA 24016, United States.
2The Department of Medicine Statistics Core, David Geffen School of Medicine at UCLA, Los Angeles, CA 90024, United States.
3Virginia Health Information, Richmond, VA 23219, United States.
4Virginia Center for Health Innovation, Henrico, VA 23233, United States.
5Milliman MedInsight, Seattle, WA 98101, United States.
6Center for Value-Based Insurance Design, University of Michigan School of Medicine and School of Public Health, Ann Arbor, MI 48109, United States.
7Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine at UCLA, Los Angeles, CA 90024, United States.
8RAND Health Care, RAND Corporation, Santa Monica, CA 90401, United States.
PubMed PMC DOI PDF

Abstract

Characterizing the value and equity of care delivered during the COVID-19 pandemic is crucial to uncovering health system vulnerabilities and informing postpandemic recovery. We used insurance claims to evaluate low-value (no clinical benefit, potentially harmful) and clinically indicated utilization of a subset of 11 ambulatory services within a cohort of ∼2 million Virginia adults during the fir…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.